Neuburgh Advisers’s Core Laboratories CLB Stock Holding History

Neuburgh Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$232K	Buy	4,976 +944	+23%	+$43.9K	0.01%	650
2019 Q2	$211K	Hold	4,032	–	–	0.01%	679
2019 Q1	$278K	Hold	4,032	–	–	0.01%	596
2018 Q4	$241K	Hold	4,032	–	–	0.01%	593
2018 Q3	$467K	Buy	4,032 +544	+16%	+$61.4K	0.02%	476
2018 Q2	$440K	Sell	3,488 -656	-16%	-$79.8K	0.01%	459
2018 Q1	$448K	Sell	4,144 -1,520	-27%	-$168K	0.02%	437
2017 Q4	$621K	Sell	5,664 -1,808	-24%	-$180K	0.02%	373
2017 Q3	$737K	Buy	7,472 +2,432	+48%	+$236K	0.03%	321
2017 Q2	$510K	Sell	5,040 -1,696	-25%	-$183K	0.02%	385
2017 Q1	$778K	Hold	6,736	–	–	0.03%	302
2016 Q4	$809K	Buy	+6,736	New	+$746K	0.04%	270

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuburgh Advisers's CLB Position: Q3 2019 in Review

Neuburgh Advisers increased its Core Laboratories (CLB) stake by 23% in Q3 2019, buying an estimated $43.9K and bringing the position to 4,976 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #650.

Neuburgh Advisers first reported a position in CLB in Q4 2016 and has held it in 12 quarters since. The position peaked at $809K in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Neuburgh Advisers held 4,976 shares of Core Laboratories worth $232K as of Q3 2019.
Neuburgh Advisers bought 944 Core Laboratories shares in Q3 2019, an estimated $43.9K.
Core Laboratories made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #650 holding.
Neuburgh Advisers first reported a position in Core Laboratories in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Core Laboratories position peaked at $809K in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.